(Q47695204)

English

The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.

scientific article published in August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644660%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644660%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

Paulette Conget

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644660%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Fernando Ezquer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644660%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Marcelo Ezquer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644660%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

David Contador

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644660%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Micaela Ricca

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644660%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Valeska Simon

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644660%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

1 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644660%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644660%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644660%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644660%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1664-1674

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644660%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Bone marrow-derived stem cell transplantation for the treatment of insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Mesenchymal stem cells: biology and potential clinical uses

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

The antidiabetic effect of MSCs is not impaired by insulin prophylaxis and is not improved by a second dose of cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Immune modulation by mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Mesenchymal stem cells as trophic mediators

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Early manifestations in multiple-low-dose streptozotocin-induced diabetes in mice

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: Influence of inbred background, sex, and thymus

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Streptozotocin-Induced Pancreatic Insulitis: New Model of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Analyzing real-time PCR data by the comparative C(T) method

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

beta-Cell death during progression to diabetes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Global estimates of the prevalence of diabetes for 2010 and 2030

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Immunological applications of stem cells in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Potential of mesenchymal stem cell therapy

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Autoimmune Diseases as the Loss of Active “Self‐Control”

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Beta cell expression of IGF-I leads to recovery from type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Hepatocyte Growth Factor Gene Therapy for Pancreatic Islets in Diabetes: Reducing the Minimal Islet Transplant Mass Required in a Glucocorticoid-Free Rat Model of Allogeneic Portal Vein Islet Transplantation

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

"Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs).

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Pharmacological treatment of chronic diabetes by stimulating pancreatic beta-cell regeneration with systemic co-administration of EGF and gastrin

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Cytokines interleukin-1beta and tumor necrosis factor-alpha regulate different transcriptional and alternative splicing networks in primary beta-cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1132

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47695204&oldid=1445767231"